复合磷酸氢钾注射液不合理用药分析  

Analysis of Irrational Drug Use in Composite Potassium Hydrogen Phosphate Injection

作　　者：徐萌[1] 杨卉[1] 张天琼[1] 倪慧珍[1] 李永莲 XU Meng;YANG Hui;ZHANG Tian-qiong;NI Hui-zhen;LI Yong-lian(Department of Clinical Pharmacy,Affiliated Hospital of Qinghai University,Xining 810001,Qinghai,China;Department of Pharmacy,Golmud Second People's Hospital,Golmud 816000,Qinghai,China)

机构地区：[1]青海大学附属医院临床药学科,青海西宁810001 [2]格尔木第二人民医院药剂科,青海格尔木816000

出　　处：《医学信息》2018年第1期133-135,共3页Journal of Medical Information

摘　　要：目的了解复合磷酸氢钾注射液不合理使用情况,为临床合理用药提供参考。方法回顾性分析某三甲医院2016年全年所有使用复合磷酸氢钾注射液的住院患者病历,了解复合磷酸氢钾注射液不合理使用情况。结果 60例中,主要为溶媒量不足47例(78.30%),主要集中在泌尿外科;其次为无适应证用药18例(30.00%),主要集中胃肠外科,肝胆科。结论复合磷酸氢钾注射液不合理用药现象比较严重,亟待加强培训及管理。Objective To understand the irrational use of composite potassium hydrogen phosphate injection,to provide reference for clinical rational drug use.Methods A retrospective analysis of all the use of composite potassium hydrogen phosphate injection in a hospital in 2016 the year of the medical records of hospitalized patients,to understand composite potassium hydrogen phosphate injection does not make a rational use of the situation.Results In 60 cases,mainly for the solvent quantity less than 47 cases(78.30%),mainly concentrated in the department of urology;second to none indications of medication in 18 cases(30.00%),the main concentration of gastrointestinal surgery,hepatobiliary.Conclusion The irrational use of composite potassium hydrogen phosphate injection is more serious,and need to strengthen training and management.

关 键 词：复合磷酸氢钾注射液 不合理用药 适应证 溶媒量 

分 类 号：R917[医药卫生—药物分析学]